Joint Filing AgreementJoint Filing Agreement • March 4th, 2021 • AI Pan LLC • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2021 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • April 2nd, 2021 • AI Pan LLC • Pharmaceutical preparations
Contract Type FiledApril 2nd, 2021 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
TENDER AND SUPPORT AGREEMENTTender and Support Agreement • March 4th, 2021 • AI Pan LLC • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 4th, 2021 Company Industry JurisdictionThis TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of February 24, 2021, is entered into by and among AI Pan LLC (“Stockholder”), Merck Sharp & Dohme Corp., a New Jersey corporation (“Parent”) and Panama Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).